Two AI-powered solutions redefine how 2,000+ specialist medical publishers and healthcare advertisers connect—securely, compliantly, and at scale. SHORT HILLS, Two AI-powered solutions redefine how 2,000+ specialist medical publishers and healthcare advertisers connect—securely, compliantly, and at scale. SHORT HILLS,

Doceree Sets the Global Standard for Healthcare Marketing, Building the World’s Largest Network of Specialist Medical Publishers

2026/01/16 19:30
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Two AI-powered solutions redefine how 2,000+ specialist medical publishers and healthcare advertisers connect—securely, compliantly, and at scale.

SHORT HILLS, N.J., Jan. 16, 2026 /PRNewswire/ — Doceree, the only AI-powered Operating System for healthcare marketing, today announced a defining industry milestone: the creation of the world’s largest network of specialist medical publishers, connecting more than 2,000 premium medical, clinical, and professional publishing platforms with endemic healthcare advertisers through its healthcare-native AI platform suite.

This global network includes some of the most trusted medical publishing brands in the world and represents a fundamental shift in how healthcare media is monetized, measured, and scaled—away from generic ad technology and towards AI-first infrastructure built exclusively for regulated clinical environments.

A Structural Shift in Healthcare Media

Doceree’s publisher network milestone is powered by the launch of two breakthrough AI-driven solutions introduced in 2025:

  • AdManager — the industry’s first unified ad management and monetization platform built exclusively for healthcare publishers
  • Premium Programmatic — a programmatic advertising solution powered by patented MeSH Taxonomy, designed to engage physicians at their most critical reading and learning moments

Together, these solutions redefine how publishers unlock demand and how pharmaceutical and life sciences brands reach healthcare professionals—with precision, compliance, and contextual relevance.

As healthcare publishers increasingly outgrew broad-market ad platforms (that were never intended for regulated clinical ecosystems), Doceree’s purpose-built approach saw rapid adoption across the world’s most trusted medical publishers.

“Partnering with Doceree has been transformative for our global strategy,” said Andy May, Global Head of Promotions – Clinical, Springer Nature. “We’ve strengthened our footprint and seen a clear uplift in yield from endemic advertisers—without compromising trust or experience.”

Why Pharma Brands Are Shifting Programmatic Spend to Doceree

What differentiates Doceree’s network is not scale alone—it is the healthcare-specific intelligence embedded into every placement. Doceree delivers three advantages traditional programmatic platforms cannot match:

More Reach — Verified, Not Aggregated

  • 2,000+ directly integrated specialist medical platforms
  • 6M+ verified healthcare professionals across 45+ specialties
  • Direct publisher relationships—no resold or blind inventory

More Context — Precision Built for Medicine

  • Patented MeSH taxonomy of 7M+ clinical keywords
  • Real-time contextual targeting aligned with medical content
  • Deterministic NPI-based identity matching, enhanced with specialty and device-level intelligence

More Formats — Designed for How Physicians Learn

  • Sponsored scientific content, clinical case studies, and CME partnerships
  • Programmatically delivered branded articles within trusted environments
  • Integration with RepTwin, Doceree’s AI-powered virtual representative available to physicians 24×7

The result is healthcare marketing that feels useful, credible, and clinically relevant, transforming advertising into meaningful medical dialogue.

“Healthcare marketing has outgrown generic programmatic models,” said Harshit Jain, MD, Founder & Global CEO, Doceree. “What we’ve built with this publisher network is not just scale, but infrastructure—designed specifically for regulated, clinical environments. By connecting trusted medical publishers directly with endemic healthcare demand, we’re setting a new global standard for how meaningful, compliant, and accountable HCP engagement should work.”

A Purpose-Built Playground for Healthcare Publishers

For publishers, the shift to healthcare-native technology unlocked capabilities that generic ad platforms could never deliver—especially the ability to activate highly targeted, physician-only campaigns without compromising editorial integrity or user experience.

“AdManager allowed us to activate precision physician campaigns while protecting the reader experience,” said Sarah Mayes, Director of Advertising, Taylor & Francis. “Every impression carried intent and value.”

Unlike broad-market ad technology that treats healthcare as an edge case, AdManager and Premium Programmatic were engineered from the ground up for healthcare publishing realities.

“A dedicated healthcare ad manager was long overdue—and Doceree delivered,” said Nicola Harris, Agency Account Director, Cogora.

A Clear Industry Signal

For publishers, Doceree delivers access to the deepest pool of endemic healthcare demand, higher CPMs, automated compliance monitoring, intelligent inventory management, and streamlined operations—all through a single healthcare-native platform.

“Healthcare publishers have outgrown generic ad platforms,” said Vijay Adapala, EVP – Global Supply Partnerships, Doceree. “The growth of our publisher network confirms a clear industry shift toward solutions that prioritize relevance, compliance, and sustainable revenue.”

With continued investment in AI, infrastructure, and global partnerships, Doceree plans multiple enhancements to AdManager and Premium Programmatic in 2026—further cementing its leadership in healthcare programmatic marketing.

Learn more:
AdManager — http://docereeadmanager.com
Premium Programmatic — https://doceree.com/premium-programmatic/

About Doceree

Doceree is the only AI-powered operating system for healthcare marketing. We believe the role of AI is to bring richer context to every HCP interaction. Our patented AI understands multiple layers of clinical, behavioral, and contextual signals to enhance every HCP interaction in a privacy-compliant manner, delivering measurably better outcomes every time. In just five years, we have emerged as leaders in AI-powered, hyper-personalized healthcare messaging—redefining HCP engagement with more powerful context and more powerful outcomes.

To learn more, visit www.doceree.ai

Photo: https://mma.prnewswire.com/media/2863437/DOCEREE_Global_Standard.jpg
Logo: https://mma.prnewswire.com/media/1758952/5721641/Doceree_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/doceree-sets-the-global-standard-for-healthcare-marketing-building-the-worlds-largest-network-of-specialist-medical-publishers-302663327.html

SOURCE Doceree

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Mutuum Finance (MUTM) Update: V1 Protocol Goes Live, Key Mechanisms Explained

Mutuum Finance (MUTM) Update: V1 Protocol Goes Live, Key Mechanisms Explained

The start of April 2026 marks a significant turning point for the decentralized world. While many older networks are struggling with slow growth and high fees,
Share
Techbullion2026/04/02 19:46
Unlocking Massive Value: Curve Finance Revenue Sharing Proposal for CRV Holders

Unlocking Massive Value: Curve Finance Revenue Sharing Proposal for CRV Holders

BitcoinWorld Unlocking Massive Value: Curve Finance Revenue Sharing Proposal for CRV Holders The dynamic world of decentralized finance (DeFi) is constantly evolving, bringing forth new opportunities and innovations. A significant development is currently unfolding at Curve Finance, a leading decentralized exchange (DEX). Its founder, Michael Egorov, has put forth an exciting proposal designed to offer a more direct path for token holders to earn revenue. This initiative, centered around a new Curve Finance revenue sharing model, aims to bolster the value for those actively participating in the protocol’s governance. What is the “Yield Basis” Proposal and How Does it Work? At the core of this forward-thinking initiative is a new protocol dubbed Yield Basis. Michael Egorov introduced this concept on the CurveDAO governance forum, outlining a mechanism to distribute sustainable profits directly to CRV holders. Specifically, it targets those who stake their CRV tokens to gain veCRV, which are essential for governance participation within the Curve ecosystem. Let’s break down the initial steps of this innovative proposal: crvUSD Issuance: Before the Yield Basis protocol goes live, $60 million in crvUSD will be issued. Strategic Fund Allocation: The funds generated from the sale of these crvUSD tokens will be strategically deployed into three distinct Bitcoin-based liquidity pools: WBTC, cbBTC, and tBTC. Pool Capping: To ensure balanced risk and diversified exposure, each of these pools will be capped at $10 million. This carefully designed structure aims to establish a robust and consistent income stream, forming the bedrock of a sustainable Curve Finance revenue sharing mechanism. Why is This Curve Finance Revenue Sharing Significant for CRV Holders? This proposal marks a pivotal moment for CRV holders, particularly those dedicated to the long-term health and governance of Curve Finance. Historically, generating revenue for token holders in the DeFi space can often be complex. The Yield Basis proposal simplifies this by offering a more direct and transparent pathway to earnings. By staking CRV for veCRV, holders are not merely engaging in governance; they are now directly positioned to benefit from the protocol’s overall success. The significance of this development is multifaceted: Direct Profit Distribution: veCRV holders are set to receive a substantial share of the profits generated by the Yield Basis protocol. Incentivized Governance: This direct financial incentive encourages more users to stake their CRV, which in turn strengthens the protocol’s decentralized governance structure. Enhanced Value Proposition: The promise of sustainable revenue sharing could significantly boost the inherent value of holding and staking CRV tokens. Ultimately, this move underscores Curve Finance’s dedication to rewarding its committed community and ensuring the long-term vitality of its ecosystem through effective Curve Finance revenue sharing. Understanding the Mechanics: Profit Distribution and Ecosystem Support The distribution model for Yield Basis has been thoughtfully crafted to strike a balance between rewarding veCRV holders and supporting the wider Curve ecosystem. Under the terms of the proposal, a substantial portion of the value generated by Yield Basis will flow back to those who contribute to the protocol’s governance. Returns for veCRV Holders: A significant share, specifically between 35% and 65% of the value generated by Yield Basis, will be distributed to veCRV holders. This flexible range allows for dynamic adjustments based on market conditions and the protocol’s performance. Ecosystem Reserve: Crucially, 25% of the Yield Basis tokens will be reserved exclusively for the Curve ecosystem. This allocation can be utilized for various strategic purposes, such as funding ongoing development, issuing grants, or further incentivizing liquidity providers. This ensures the continuous growth and innovation of the platform. The proposal is currently undergoing a democratic vote on the CurveDAO governance forum, giving the community a direct voice in shaping the future of Curve Finance revenue sharing. The voting period is scheduled to conclude on September 24th. What’s Next for Curve Finance and CRV Holders? The proposed Yield Basis protocol represents a pioneering approach to sustainable revenue generation and community incentivization within the DeFi landscape. If approved by the community, this Curve Finance revenue sharing model has the potential to establish a new benchmark for how decentralized exchanges reward their most dedicated participants. It aims to foster a more robust and engaged community by directly linking governance participation with tangible financial benefits. This strategic move by Michael Egorov and the Curve Finance team highlights a strong commitment to innovation and strengthening the decentralized nature of the protocol. For CRV holders, a thorough understanding of this proposal is crucial for making informed decisions regarding their staking strategies and overall engagement with one of DeFi’s foundational platforms. FAQs about Curve Finance Revenue Sharing Q1: What is the main goal of the Yield Basis proposal? A1: The primary goal is to establish a more direct and sustainable way for CRV token holders who stake their tokens (receiving veCRV) to earn revenue from the Curve Finance protocol. Q2: How will funds be generated for the Yield Basis protocol? A2: Initially, $60 million in crvUSD will be issued and sold. The funds from this sale will then be allocated to three Bitcoin-based pools (WBTC, cbBTC, and tBTC), with each pool capped at $10 million, to generate profits. Q3: Who benefits from the Yield Basis revenue sharing? A3: The proposal states that between 35% and 65% of the value generated by Yield Basis will be returned to veCRV holders, who are CRV stakers participating in governance. Q4: What is the purpose of the 25% reserve for the Curve ecosystem? A4: This 25% reserve of Yield Basis tokens is intended to support the broader Curve ecosystem, potentially funding development, grants, or other initiatives that contribute to the platform’s growth and sustainability. Q5: When is the vote on the Yield Basis proposal? A5: A vote on the proposal is currently underway on the CurveDAO governance forum and is scheduled to run until September 24th. If you found this article insightful and valuable, please consider sharing it with your friends, colleagues, and followers on social media! Your support helps us continue to deliver important DeFi insights and analysis to a wider audience. To learn more about the latest DeFi market trends, explore our article on key developments shaping decentralized finance institutional adoption. This post Unlocking Massive Value: Curve Finance Revenue Sharing Proposal for CRV Holders first appeared on BitcoinWorld.
Share
Coinstats2025/09/18 00:35
Oscar Health (OSCR) Stock Soars 11% on Record-Breaking Quarterly Earnings

Oscar Health (OSCR) Stock Soars 11% on Record-Breaking Quarterly Earnings

Oscar Health (OSCR) stock rallied 11% after delivering record $679M profit, $2.07 EPS (vs $1.06 estimate), and 57% membership growth year-over-year. The post Oscar
Share
Blockonomi2026/05/06 19:52

Starter Gold Rush: Win $2,500!

Starter Gold Rush: Win $2,500!Starter Gold Rush: Win $2,500!

Start your first trade & capture every Alpha move